One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
PDF Availablehttps://doi.org/10.1136/jitc-2023-sitc2023.0724
Copy DOI
Export
Save
Share
Cite Journal: Journal for ImmunoTherapy of Cancer |  Publication Date: Nov 1, 2023 |
 License type: CC BY-NC 4.0 |
Affiliation: Angeles Clinic and Research Institute, The University of Texas MD Anderson Cancer Center, Georgetown University, Center for Cancer and Blood Disorders, Utah Cancer Specialists, University of Cincinnati, Atlantic Health System, Fox Chase Cancer Center, Hollings Cancer Center, Wayne State University, Alkermes (United States), Roswell Park Cancer Institute
BackgroundNemvaleukin alfa (nemvaleukin, ALKS 4230) is a novel, engineered cytokine that selectively binds to the intermediate-affinity interleukin-2 receptor to preferentially activate antitumor CD8+ T cells and natural killer cells, with...
Free) 
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
